William Ackman
Bill Ackman runs hedge fund Pershing Square Capital, which he started in 2003 following the dissolution of Gotham Partners.
Ackman is a value investor with an activist bent. Activist investors agitate management for changes. He owns large positions in Target (NYSE: TGT) and Borders (NYSE: BGP). He has also been involved in activist situations at Wendy's (NYSE: WEN) and McDonald's (NYSE: MCD).
Ackman proved his acumen as a short seller in 2007/2008 as short positions he held in MBIA (NYSE: MBI) and Ambac (NYSE: ABK) proved to be big winners due to the credit crunch.
In July 2008, Ackman said he was short the common stock of Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE). Ackman also laid out a plan to reorganize the GSEs, which would wipe out the common shareholders.
View Older Stories View More Recent Stories
-
Mizuho Sees More Volatility for Valeant (VRX) Amid Changes
-
Drugmaker Valeant CEO leaving as investor Ackman joins board
-
Valeant Pharma (VRX) to Replace CEO Pearson; Adds Bill Ackman to Board
-
Valeant Announces CEO Succession Plan And Changes To Board Of Directors; Provides Accounting And Financial Reporting Update
-
Wall St. ends flat as recent rally spurs caution
-
S&P says it may cut Ackman hedge fund's rating
-
Herbalife (HLF) Creeps Higher on Anti-Ackman Trade
-
Bill Ackman tells CNBC Valeant (VRX) "is a problem but we know what to do."
-
Bill Ackman tells CNBC next redemption Mid-May
-
Bill Ackman tells CNBC 'we don't use margin leverage - never have and never will' (VRX)
-
Valeant Pharma (VRX) Gains on Ackman Chatter
-
Ackman Said to Add to Valeant Pharma (VRX) Stake - Chatter
-
Ackman's Pershing Square Said to Support Valeant Pharma (VRX) CEO Pearson; Wants More Oversight - Bloomberg
-
Ackman's Pershing Square Said Down $666M+ This Week on Valeant Pharma (VRX) Stake
-
Drugmaker Valeant faces debt default risk; shares plunge 50 percent
-
Valeant under pressure to beef up management as new board meets
-
Valeant gives Pershing Square 1 board seat, adds 2 other directors
-
Valeant gives Pershing Square a seat on its board
-
After-Hours Stock Movers 03/08: (BUFF) (CISG) (AVAV) Higher; (STEM) (PLNT) (ZAGG) Lower (more...)
-
Valeant Pharma (VRX) Said in Talks to Add New Director; May Come from Ackman's Pershing Square
-
Ackman's Pershing Square Holdings down 18.6 percent so far in 2016: investor
-
'No Blatant Lies' Seen from Valeant (VRX) CEO/CFO Exchange and Philidor Scripts Were Not Just Smoke and Mirrors - Evercore ISI
-
Ackman acknowledges mistakes in 2015, details changes in portfolio
-
U.S. hedge funds boast lower losses as markets tumble further
-
Pershing Square's Ackman Thinks Interim Valeant (VRX) CEO Schiller Will Do 'Outstanding Job'
-
Valeant Pharma (VRX) Sees Sharp Upside
-
Ackman's Pershing Square ends 2015 with 20.5 pct drop
-
Ackman's Pershing Square Sold Nearly 5M Shares of Valeant Pharma (VRX) for Tax Purposes
-
Ackman's Pershing Square Having an Up Month in December
-
Valeant says can contain hit to dermatology, projects 2016 growth
-
Ackman tells investors that this year could be his firm's worst ever
-
Valeant Pharma (VRX) CEO Pearson Says Walgreens Deal 'More than Replaces' Philidor
-
Ackman plays big role in laying out Canadian Pacific rail deal
-
Pre-Open Stock Movers 11/24: (SUNE) (TASR) (BDBD) Higher; (UNXL) (CHS) (KBIO) Lower (more...)
-
After-Hours Movers 11/23: (XRX) (DY) (VRX) Higher; (BRCD) (CERE) (YY) Lower (more...)
-
Bill Ackman 'has killed Pershing Square. Its over'- Hempton (VRX)
-
Ackman boosts stake in drugmaker Valeant
-
Market Wrap: Pfizer, Allergan Make it Offiical; Icahn Gets Active on Xerox; Existing Sales Slump in Oct.
-
Ackman's Pershing Square Capital Raises Stake in Valeant Pharmaceuticals (VRX) to 9.9%
-
Ackman's Pershing Square Moves Stake in Valeant Pharma (VRX) to 9.9%
-
Hedge funds' favorite stocks lag broader market: Goldman data
-
Ackman's Pershing Square Holdings off 24.5 percent YTD
-
Norfolk Southern hostile to Canadian Pacific's $28.4 billion bid
-
Ackman discusses long Valeant Pharma (VRX), short Herbalife (HLF) at Robin Hood
-
Ackman's Pershing Square 13F Shows 43.37M Stake in Mondelez (MDLZ), Maintained Air Products (APD), Canadian Pacific (CP), Valeant (VRX)
-
Ackman's Pershing Square Down 2.8% MTD, 21.2% YTD
-
Valeant, Ackman must face U.S. insider trading lawsuit
-
Market Wrap: OECD Warns on Trade Growth; Citron Selects New Target; DuPont Names New Chief
-
Ackman says Valeant stock 'extraordinary bargain'
-
Bill Ackman sees Valeant Pharma (VRX) de-levering dramatically over the next 18-24 months - Bloomberg

